PhRMA Urges Japan To Create Separate Regulations For Biosimilars

TOKYO - The Pharmaceutical Research and Manufacturers of America called on Japan to create a separate regulatory structure for biosimilar drugs from branded biologics, a day after the Ministry of Health, Labor and Welfare released a draft biosimilar guideline Sept. 17